Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from COPD

Chronic Lung Disease Warning Signs: Recognize COPD Symptoms Before It's Too Late

Learn the early warning signs of COPD and chronic lung disease symptoms. Discover causes, diagnosis, and when to seek medical help for better health outcomes.

Medical Daily

Asthma vs COPD: How to Spot the Symptoms and Understand Your Breathing Problems

COPD and asthma share similar breathing problems, but their causes, symptoms, and treatments differ. Learn the key distinctions to manage these conditions effectively.

Medical Daily

Epic Gamer Grandma Dies from COPD — Fans Mourn TikToker Who Changed Gaming

Learn about Epic Gamer Grandma, the beloved TikTok star who passed away and inspired millions with her gaming spirit and warm presence.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

People in poorest areas of England ‘more likely to need emergency care for lung conditions’

Analysis finds those from most deprived backgrounds almost twice as likely to be admitted to hospital for respiratory conditions

The Guardian - UK

Strictly’s Shirley Ballas reveals ‘scary’ reality of mother’s lung condition

‘It’s quite sad, it’s debilitating, and also it’s never going to get any better,’ says Strictly judge

The Independent UK

Shirley Ballas says impact of her mum’s lung condition is ‘really quite scary’

The 65-year-old said she will speak to MPs in Parliament to raise awareness of chronic obstructive pulmonary disease (COPD).

Evening Standard

People in poorer health ‘more likely to vote Reform UK’

Among the conditions linked to voting for Reform were asthma, chronic obstructive pulmonary disease (COPD), kidney disease and depression.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

Benzinga

Study finds singing these three songs could help treat lung disease

Researchers may have found a safe and effective treatment for chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)

The Independent UK

Singing songs by Elvis and The Beatles can help lung patients – study

A new study saw patients given singing therapy in group sessions online.

Evening Standard

Three new cancer drugs approved for use for NHS Scotland

Three new treatments for cancer have been approved for use by the NHS in Scotland ...

The National (Scotland)

Is Sylvester Stallone Dead? Not The Actor But The Funk Frontman Sly Stone: Cause Of Death And What We Know

Sly Stone, funk legend and frontman of Sly and the Family Stone, died at 82 from COPD complications. Actor Sylvester Stallone is alive despite online confusion.

International Business Times UK

“A monumental figure, a groundbreaking innovator, and a true pioneer who redefined the landscape of pop, funk, and rock music”: Sly Stone, restlessly creative musical giant who led Sly and the Family Stone, dies at 82

The visionary multi-instrumentalist, singer, and songwriter had been battling COPD, according to his family

Guitar World

Lung disease test done by AI to be rolled out in GP surgeries

‘Game-changing’ AI-driven lung test set for GP surgery rollout

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

‘Game-changing’ AI-driven lung test set for GP surgery rollout

The device, known as N-Tidal Diagnose, uses carbon dioxide sensors to measure changes in a patient’s lung function with results given in minutes.

MarketBeat

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

The Independent UK

David Lynch death: What are the symptoms and causes of emphysema?

The biggest risk is smoking

International Business Times

UK Using AI To Cut Patient Hospital Visits

The government in the United Kingdom is using artificial intelligence (AI) in the healthcare industry to cut down on hospital visits, having already seen a 40% reduction in the number of COPD patients.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

First new treatment for asthma and COPD in half a century – new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

Medical Daily

New Treatment For Asthma, COPD Flare-Ups: Single Dose Of Existing Antibody Injection May Cut Hospitalizations

A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.

Evening Standard

What is benralizumab? Breakthrough asthma drug hailed a 'game-changer'

The injection is the first new treatment for asthma and COPD attacks in 50 years

Evening Standard

Benralizumab: London scientists create 'game-changing' first treatment for asthma attacks in 50 years

Researchers say injection will be ‘game changing’ for people with the respiratory condition

The Guardian - UK

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world

The Independent UK

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells

Evening Standard

First treatment in 50 years for serious asthma attacks is ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Enanta Pharmaceuticals

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.